Rhinovirus type 14 RNA polymerase complexes.
Rhinovirus type 14 RNA-dependent RNA polymerase complexes were isolated from microsomal and soluble fraction of infected KB cells. Maximum activities were measured at at 6 and 7 hours post inoculation (p.i.) for microsomal and soluble polymerases, respectively. Both polymerase activities are considerably reduced by 8 to 9 hours, p.i., and interval in which the in vivo rate of synthesis of viral RNA is maximal. In vitro RNA products of RNA polymerases in both fractions consist of ribonuclease-sensitive and ribonuclease-resistant RNA of heterogeneous sizes. Detergent treatment of the microsomal RNA polymerase(s) did not affect the total amount of RNA synthesized, the proportion of ribonuclease-sensitive RNA synthesized or the size of the RNA products. The data suggest that RV14RNA polymerase complexes are intially associated with membranes but are then irreversibly released into the soluble phase of the cytoplasm; possible explanations for this phenomena are discussed.
D002277:Carcinoma; D002458:Cell Fractionation; D002460:Cell Line; D002474:Cell-Free System; D002499:Centrifugation, Density Gradient; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D006801:Humans; D008861:Microsomes / Q000201:enzymology; D009062:Mouth Neoplasms; D009097:Multienzyme Complexes / Q000378:metabolism; D012367:RNA, Viral / Q000096:biosynthesis; D012229:Rhinovirus / Q000201:enzymology* / Q000378:metabolism; D012260:Ribonucleases / Q000494:pharmacology; D012995:Solubility; D013347:Subcellular Fractions / Q000201:enzymology; D013501:Surface-Active Agents / Q000494:pharmacology; D013997:Time Factors
D009097:Multienzyme Complexes; D012367:RNA, Viral; D013501:Surface-Active Agents; D003609:Dactinomycin; D012321:DNA-Directed RNA Polymerases; D012260:Ribonucleases